JP2001501207A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001501207A5 JP2001501207A5 JP1998515724A JP51572498A JP2001501207A5 JP 2001501207 A5 JP2001501207 A5 JP 2001501207A5 JP 1998515724 A JP1998515724 A JP 1998515724A JP 51572498 A JP51572498 A JP 51572498A JP 2001501207 A5 JP2001501207 A5 JP 2001501207A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2663396P | 1996-09-24 | 1996-09-24 | |
| US60/026,633 | 1996-09-24 | ||
| PCT/US1997/016547 WO1998013027A1 (en) | 1996-09-24 | 1997-09-18 | Coated particle formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001501207A JP2001501207A (ja) | 2001-01-30 |
| JP2001501207A5 true JP2001501207A5 (enExample) | 2005-05-12 |
Family
ID=21832952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10515724A Ceased JP2001501207A (ja) | 1996-09-24 | 1997-09-18 | コーティングされた粒子製剤 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20010020032A1 (enExample) |
| EP (1) | EP0830858A1 (enExample) |
| JP (1) | JP2001501207A (enExample) |
| KR (1) | KR20000048540A (enExample) |
| CN (1) | CN1230883A (enExample) |
| AR (1) | AR009802A1 (enExample) |
| AU (1) | AU719788B2 (enExample) |
| BR (1) | BR9713215A (enExample) |
| CA (1) | CA2266448A1 (enExample) |
| CO (1) | CO4910139A1 (enExample) |
| CZ (1) | CZ98899A3 (enExample) |
| EA (1) | EA001610B1 (enExample) |
| HU (1) | HUP9904065A3 (enExample) |
| ID (1) | ID21762A (enExample) |
| IL (1) | IL128845A0 (enExample) |
| NO (1) | NO991405D0 (enExample) |
| PE (1) | PE27899A1 (enExample) |
| PL (1) | PL332503A1 (enExample) |
| TR (1) | TR199900651T2 (enExample) |
| WO (1) | WO1998013027A1 (enExample) |
| ZA (1) | ZA978517B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9922271D0 (en) * | 1999-09-21 | 1999-11-17 | Zeneca Ltd | Formulation |
| TWI275394B (en) * | 2000-01-26 | 2007-03-11 | Asahi Chemical Corp | Mizoribin tablet improved with color tone change |
| US6740753B2 (en) | 2001-01-04 | 2004-05-25 | Geneva Pharmaceuticals, Inc. | Olanzapine crystal modification |
| DE10232113A1 (de) * | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
| SI21303A (sl) * | 2002-10-18 | 2004-04-30 | Krka, Tovarna Zdravil, D.D.,, Novo Mesto | Farmacevtska formulacija olanzapina |
| EP1585500B8 (en) | 2002-12-20 | 2017-07-26 | Auritec Pharmaceuticals | Coated particles for sustained-release pharmaceutical administration |
| SI21402A (sl) | 2003-02-12 | 2004-08-31 | LEK farmacevtska dru�ba d.d. | Obloženi delci in farmacevtske oblike |
| CN100563648C (zh) * | 2003-04-25 | 2009-12-02 | 田边三菱制药株式会社 | 包含亚烷基二氧苯衍生物的口服组合物 |
| WO2005009407A2 (en) * | 2003-07-29 | 2005-02-03 | Ranbaxy Laboratories Limited | Oral pharmaceutical formulations of olanzapine |
| WO2006027800A1 (en) * | 2004-09-06 | 2006-03-16 | Shasun Chemicals And Drugs Limited | A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine |
| CZ297214B6 (cs) * | 2005-02-02 | 2006-10-11 | Zentiva, A. S. | Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby |
| WO2007049304A2 (en) * | 2005-10-27 | 2007-05-03 | Jubilant Organosys Limited | Stable coated pharmaceutical formulation of olanzapine and process for preparing the same |
| ES2279715B1 (es) * | 2005-12-26 | 2008-06-01 | Laboratorios Lesvi, S.L. | Formulacion oral de olanzapina. |
| US20070293479A1 (en) * | 2006-05-18 | 2007-12-20 | Osinga Niels J | Olanzapine pharmaceutical composition |
| WO2008004033A1 (en) * | 2006-07-05 | 2008-01-10 | Bilim Ilac Sanayii Ve Ticaret A.S. | A stable olanzapine formulation with antioxidants |
| US20080138409A1 (en) * | 2006-09-29 | 2008-06-12 | Osinga Niels J | Olanzapine pharmaceutical composition |
| DK2563763T3 (en) * | 2010-04-30 | 2015-04-07 | Bristol Myers Squibb Co | PHARMACEUTICAL COMPOSITIONS CONTAINING N- (4- (2-AMINO-3-CHLORPYRIDIN-4-YLOXY) -3-FLUORPHENYL) -4-ETHOXY-1- (4-FLUORPHENYL) -2-OXO-1,2-DIHYDROPYRIDE - 3-CARBOXAMID |
| WO2012153347A2 (en) | 2011-05-04 | 2012-11-15 | Zentiva K.S. | Oral pharmaceutical composition of olanzapine form 1 |
| RU2015144689A (ru) | 2013-03-21 | 2017-04-25 | ЮПРАКСИЯ ФАРМАСЬЮТИКАЛЗ ЮЭсЭй ЭлЭлСи | Композиция для инъекций с замедленным высвобождением и способ ее применения для лечения воспаления в суставах и связанной с такими воспалениями боли |
| AU2016343952A1 (en) | 2015-10-27 | 2018-05-10 | Eupraxia Pharmaceuticals Inc. | Sustained release formulations of local anesthetics |
| CN107007559B (zh) * | 2017-04-21 | 2020-05-15 | 浙江京新药业股份有限公司 | 一种稳定的口服药物组合物及其制备方法 |
| US10377708B2 (en) | 2017-12-05 | 2019-08-13 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
| EP3720434A4 (en) | 2017-12-05 | 2021-09-01 | Sunovion Pharmaceuticals Inc. | NON-RACEMIC MIXTURES AND THEIR USE |
| CN114401717A (zh) | 2019-06-04 | 2022-04-26 | 赛诺维信制药公司 | 修饰释放配制品及其用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820522A (en) * | 1987-07-27 | 1989-04-11 | Mcneilab, Inc. | Oral sustained release acetaminophen formulation and process |
| US5605897A (en) * | 1991-04-23 | 1997-02-25 | Eli Lilly And Company | 2-methyl-thieno-benzodiazepine |
| ZA922777B (en) * | 1991-04-29 | 1993-10-15 | Lilly Co Eli | Pharmaceutical formulation containing dirithromycin |
| JPH05194225A (ja) * | 1991-11-07 | 1993-08-03 | Yoshitomi Pharmaceut Ind Ltd | 安定化された抗潰瘍剤含有製剤 |
| NO305125B1 (no) * | 1992-05-29 | 1999-04-06 | Lilly Industries Ltd | Farmas°ytiske forbindelser |
| SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
| CR5278A (es) * | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
| IL117612A0 (en) * | 1995-03-24 | 1996-07-23 | Lilly Co Eli | Granule formulation for olanzapine |
| US5637584A (en) * | 1995-03-24 | 1997-06-10 | Eli Lilly And Company | Solvate of olanzapine |
-
1997
- 1997-09-18 KR KR1019990702455A patent/KR20000048540A/ko not_active Withdrawn
- 1997-09-18 EA EA199900331A patent/EA001610B1/ru not_active IP Right Cessation
- 1997-09-18 JP JP10515724A patent/JP2001501207A/ja not_active Ceased
- 1997-09-18 WO PCT/US1997/016547 patent/WO1998013027A1/en not_active Ceased
- 1997-09-18 TR TR1999/00651T patent/TR199900651T2/xx unknown
- 1997-09-18 ID IDW990060A patent/ID21762A/id unknown
- 1997-09-18 CN CN97198099A patent/CN1230883A/zh active Pending
- 1997-09-18 IL IL12884597A patent/IL128845A0/xx unknown
- 1997-09-18 PL PL97332503A patent/PL332503A1/xx unknown
- 1997-09-18 BR BR9713215-2A patent/BR9713215A/pt not_active IP Right Cessation
- 1997-09-18 HU HU9904065A patent/HUP9904065A3/hu unknown
- 1997-09-18 CA CA002266448A patent/CA2266448A1/en not_active Abandoned
- 1997-09-18 CZ CZ99988A patent/CZ98899A3/cs unknown
- 1997-09-18 AU AU44230/97A patent/AU719788B2/en not_active Ceased
- 1997-09-22 CO CO97055063A patent/CO4910139A1/es unknown
- 1997-09-22 EP EP97307380A patent/EP0830858A1/en not_active Withdrawn
- 1997-09-22 ZA ZA978517A patent/ZA978517B/xx unknown
- 1997-09-23 AR ARP970104363A patent/AR009802A1/es unknown
- 1997-09-23 PE PE1997000854A patent/PE27899A1/es not_active Application Discontinuation
- 1997-09-23 US US08/935,882 patent/US20010020032A1/en not_active Abandoned
-
1999
- 1999-03-23 NO NO991405A patent/NO991405D0/no not_active Application Discontinuation